There are disclosed compounds of formula (I) that modulate the activity of inhibitors of apoptosis (IAPs), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing said compounds.
公开了式(I)的化合物,该化合物调节凋亡
抑制剂(IAP)的活性,包含该化合物的制药组合物以及利用该化合物治疗增生性疾病和失调凋亡疾病,如癌症的方法。